Supernus Pharmaceuticals, Inc.
SUPN
Revenue
192.10M
▲26.65M▲16.11%
3 Months ChangeAssets
1.42B
▲37.35M▲2.70%
3 Months ChangeLiabilities
370.09M
▲51.58M▲16.20%
3 Months ChangeFree Cash Flow
30.27M
▼-7.88M▼-20.66%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-30
Form 8-K
ID: 0001356576-24-000062
2024-10-21
Form 8-K
ID: 0001356576-24-000060
2024-10-17
Form 8-K
ID: 0001356576-24-000058
2024-10-10
Form 8-K
ID: 0001356576-24-000056
2024-08-19
Form 8-K
ID: 0001356576-24-000053
2024-08-06
Form 10-Q
ID: 0001356576-24-000051
2024-08-06
Form 8-K
ID: 0001356576-24-000049
2024-08-01
Form 8-K
ID: 0001356576-24-000041
2024-07-23
Form 8-K
ID: 0001356576-24-000039
2024-06-17
Form 8-K
ID: 0001104659-24-072272